Ventyx Biosciences, Inc. (29)
Browse by Contract Category
Contracts
-
Form of Registration Rights Agreement, dated September 17, 2022, by and among the Company and the Purchasers
(Filed With SEC on September 19, 2022)
-
Lease by and between Charlotta Partners, Inc. and the Company, dated April 25, 2022
(Filed With SEC on August 15, 2022)
-
Executive Change in Control and Severance Plan
(Filed With SEC on May 9, 2022)
-
Executive Chairperson Services Agreement, dated as of May 14, 2021, by and between Sheila Gujrathi, M.D. and the Registrant
(Filed With SEC on March 24, 2022)
-
Confirmatory Offer Letter, dated as of October 7, 2021, by and between Martin Auster, M.D. and the Registrant
(Filed With SEC on October 15, 2021)
-
Form of Stock Purchase Agreement, dated September 17, 2022, by and among the Company and the Purchasers
(Filed With SEC on September 19, 2022)
-
Employment Letter between the Company and Dr. Sandborn, dated May 5, 2022
(Filed With SEC on May 9, 2022)
-
Description of Common Stock
(Filed With SEC on March 24, 2022)
-
2021 Equity Incentive Plan, as amended, and forms of agreement thereunder
(Filed With SEC on November 18, 2021)
-
2019 Equity Incentive Plan, as amended, and forms of agreement thereunder
(Filed With SEC on November 18, 2021)
-
Standard Multi-Tenant Office Lease, dated as of September 15, 2021, by and among Charlotta Partners, Inc., 9310 Towne Centre Drive Harrison-1, LLC and the Registrant
(Filed With SEC on October 15, 2021)
-
Confirmatory Offer Letter, dated as of October 7, 2021, by and between the Registrant and Jrn Drappa, M.D., Ph.D
(Filed With SEC on October 15, 2021)
-
Master Services Agreement, dated as of January 17, 2019, by and between the Registrant and Bayside Pharma, LLC
(Filed With SEC on October 15, 2021)
-
Lease, dated as of June 14, 2021, by and among Charlotta Partners, Inc., 9310 Towne Centre Drive Harrison-1, LLC and the Registrant
(Filed With SEC on October 15, 2021)
-
Confirmatory Offer Letter, dated as of October 7, 2021, by and between John Nuss, Ph.D. and the Registrant
(Filed With SEC on October 15, 2021)
-
Confirmatory Offer Letter, dated as of October 7, 2021, by and between Christopher Krueger, J.D., M.B.A. and the Registrant
(Filed With SEC on October 15, 2021)
-
Confirmatory Offer Letter, dated as of October 7, 2021, by and between Raju Mohan, Ph.D. and the Registrant
(Filed With SEC on October 15, 2021)
-
2021 Employee Stock Purchase Plan, to be in effect upon the completion of this offering
(Filed With SEC on October 15, 2021)
-
2021 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering
(Filed With SEC on October 15, 2021)
-
Specimen common stock certificate of the Registrant
(Filed With SEC on October 15, 2021)
-
Form of Underwriting Agreement, including form of Lock-up Agreement
(Filed With SEC on October 15, 2021)
-
Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Zomagen Biosciences Ltd. and certain of its Securityholders
(Filed With SEC on September 29, 2021)
-
Offer Letter, dated as of May 21, 2021, by and between William R. White, J.D., M.P.P. and the Registrant
(Filed With SEC on September 29, 2021)
-
Executive Chairperson Services Agreement, dated as of May 14, 2021, by and between Sheila Gujrathi, M.D. and the Registrant
(Filed With SEC on September 29, 2021)
-
2019 Equity Incentive Plan, as amended, and forms of agreement thereunder
(Filed With SEC on September 29, 2021)
-
Form of Indemnification Agreement
(Filed With SEC on September 29, 2021)
-
Amended and Restated Investors Rights Agreement, dated as of September 9, 2021, by and among the Registrant and certain of its Stockholders
(Filed With SEC on September 29, 2021)
-
Share Purchase Agreement, dated as of February 26, 2021, by and among the Registrant, Oppilan Pharma Ltd. and certain of its Securityholders
(Filed With SEC on September 29, 2021)
-
Asset Purchase Agreement, dated as of February 7, 2019, by and between Vimalan Biosciences, Inc. and the Registrant
(Filed With SEC on September 29, 2021)